Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Journal of Hematology & Oncology|July 18, 2024
Menin inhibitors for acute myeloid leukemia: latest updates from the 2023 ASH Annual MeetingZhuo-Yu An, Xiao-Hui ZhangFrontiers in Cardiovascular Medicine|April 4, 2022
Association Between Asthma and All-Cause Mortality and Cardiovascular Disease Morbidity and Mortality: A Meta-Analysis of Cohort StudiesBin Zhang, Zhi-Fei Li, Zhuo-Yu An, et al.Reviews in Cardiovascular Medicine|August 14, 2024
The Application of Mendelian Randomization in Cardiovascular Disease Risk Prediction: Current Status and Future ProspectsYi-Jing Jin, Xing-Yuan Wu, Zhuo-Yu AnWorld Journal of Gastroenterology|September 10, 2019
High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patientsWei-Bo Du, Chen-Hong Lin, Wen-Biao ChenBMC Pulmonary Medicine|July 29, 2021
Rationale and design of REGULATE: an observational study protocol for relationship between plasma metabolome and the efficacy of systemic glucocorticoid in acute exacerbation of chronic obstructive pulmonary diseaseQiu-Yu Li, Zhuo-Yu An, Zi-Han Pan, et al.Reviews in Cardiovascular Medicine|July 30, 2024
NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium OutflowYi-Jing Jin, Zhuo-Yu An, Zhi-Xuan Sun, et al.Frontiers in Cardiovascular Medicine|May 13, 2021
Associations Between the Use of Renin-Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational StudiesXiao-Ce Dai, Zhuo-Yu An, Zi-Yang Wang, et al.Journal of Zhejiang University. Science. B|March 7, 2015
Identification of microRNAs and their target genes in Alport syndrome using deep sequencing of iPSCs samplesWen-biao Chen, Jian-rong Huang, Xiang-qi Yu, et al.Frontiers in Neurology|July 11, 2022
Meta-Analysis of the Association Between Asthma and the Risk of StrokeZheng-Hua Fang, Zhi-Fei Li, Zhuo-Yu An, et al.World Journal of Clinical Cases|August 18, 2022
Ethical review of off-label drugs during the COVID-19 pandemicQiu-Yu Li, Ye Lv, Zhuo-Yu An, et al.Pageof 3